Conducting clinical research across borders?
We promote international collaboration.

Associate members

The SCTO is an independent organisation and is based on a joint initiative of the Swiss National Science Foundation and the Swiss Academy of Medical Sciences.

As of 2017, the SCTO is a research infrastructure of national importance funded by the State Secretariat of Education, Research and Innovation and the Swiss National Science Foundation.


New and better therapies through research

The Swiss Clinical Trial Organisation (SCTO) is the central cooperation platform for patient-oriented clinical research in Switzerland. Its primary objective is, in the interests of society, to attractively and competitively position Swiss clinical research in the international competition with respect to innovation and quality.

The SCTO intends to achieve this mandate by:

  • Promoting a high-quality and nationally harmonised study culture – including the continuing education necessary for this purpose
  • Supporting the formation of national networks
  • Facilitating the integration of national clinical research into international networks
  • Promoting the transfer of knowledge between basic research and therapeutic applications
  • Building bridges between the public, academia, industry and authorities
  • Advocating favourable conditions in the field of clinical research in general 

There are six hospitals in Switzerland with centres for clinical research. These Clinical Trial Units (CTUs) are located at the university hospitals in Basel, Bern, Geneva, Lausanne and Zurich and at the cantonal hospital in St. Gallen. The SCTO coordinates and enhances the cooperation between these centres for clinical research. 

The SCTO is a joint initiative of the Swiss National Science Foundation (SNSF) and the Swiss Academy of Medical Sciences (SAMS). Since 1 January 2013, the SCTO acts as an independent organisation.

For further information about our services see our latest SCTO Short Report.